Reyes-Cadena A

Language: Spanish
References: 12
Page: 122-125
PDF size: 504.06 Kb.

Text Extraction

No abstract

REFERENCES

1. Lotte A, Wasz-Hockert O, Poisson N, et al. Second IUATLD study on complications induced by intradermal BCGvaccination. Bull Int Union Tuberc Lung Dis 1988;63:47–59.

2. Goraya JS, Virdi VS. Bacille Calmette-Guérin lymphadenitis. Postgrad Med J 2002;78:327-329.

3. Greppi D, Guzmán M. Vacunas en tuberculosis. Archivos de Alergia e Inmunología Clínica 2007;38(4):148-154.

4. Chan WM, Kwan YW, Leung CW. Management of Bacillus Calmette-Guérin Lymphadenitis. HKJ Paediatr 2011;16:85-94.

5. Quezada, D.G, Meléndez M.A.G. Vacunas en tuberculosis. Archivos de Alergia e Inmunología Clínica 2007;38(4):148-154.

6. Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of bacillus Calmette Guerinvaccination of newborns and infants in the prevention of tuberculosis: metaanalyses of the published literature. Pediatrics 1995;96:29–35.

7. Talbot EA, Perkins MD, Silva SF, et al. Disseminated bacilli Calmette-Guerin disease after vaccination: case report and review. Clin Infect Dis1997;24:1139–46.

8. Norouzi S, Aghamohammadi A, Mamishi S, Rosenzweig S, RezaeiN. Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases. Journal of Infection 2012;64:543-554.

9. James J. C. Nuttall and Brian S. Eley. BCG Vaccination in HIV-Infected Children. Tuberculosis Research and Treatment, Vol. 2011, Article ID 712736, 6 pages, 2011. doi:10.1155/2011/712736

10. Goraya JS, Virdi VS. Bacille Calmette-Guérin lymphadenitis. Postgrad Med J 2002;78:327-329.

11. Chan W.M., Kwan Y.W., Leung C.W. "Management of Bacillus Calmette-Guérin Lymphadenitis." HK J Paediatr 2011;16(2):85-94.

12. Abhulhamees F, Hummaida T. Surgical Management of BCG Vaccine-Induced Regional Lymph Nodes Adverse Effects. Annals of Pediatric Surgery 2009;5(3):187-193.